Efficacy and safety of remimazolam and propofol combined with alfentanil in gynecological day surgery: a randomized controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060916

Enrollment

Unknown

Registered

2022-06-14

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control group:General anesthesia with propofol

experimental group:General anesthesia with remimazolam

Eligibility

Sex/Gender

Female

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients selected for elective gynecological day surgery in Weifang People's Hospital, ASA grade I-II, age 20-60, BMI18-28 kg/m2, signed informed consent for anesthesia.

Exclusion criteria

Exclusion criteria: 1. Morbid Obesity (BMI > 30 kg/m2); 2. Associated with coronary artery disease, liver and kidney dysfunction, neuromuscular and Psychiatric Disorders; 3. A history of cerebral infarction, myocardial infarction, and Severe Arrhythmia; 4. History of chronic pain or use of any sedatives or analgesics; 5. Allergic to any drug involved in the study.

Design outcomes

Primary

Measure	Time frame
Success rate of anesthesia induction;	—

Secondary

Measure	Time frame
Hemodynamic changes;Perioperative adverse reactions;	—

Countries

China

Contacts

Public ContactJi Fanceng

School of Anesthesiology, Weifang Medical Unibersity

jifanceng@163.com+86 13563698838

Outcome results